1,2-dipalmitoylphosphatidylcholine has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, F; Borbone, N; Castaldo, G; Cernera, G; Comegna, M; Conte, G; d'Angelo, I; D'Errico, S; Di Lullo, AM; Falanga, AP; Marzano, M; Oliviero, G; Ungaro, F | 1 |
| Al Jamal, KT; Alpar, O; Awad, G; El-Shamy, AE; Kan, PL; Mortada, N; Osman, R | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Cystic Fibrosis
| Article | Year |
|---|---|
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Airway Obstruction; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Delivery Systems; Humans; Lung; Mucus; Nanoparticles; Nasal Mucosa; Peptide Nucleic Acids; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |
Inhalable DNase I microparticles engineered with biologically active excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Chitosan; Cystic Fibrosis; Delayed-Action Preparations; Deoxyribonuclease I; Dextrans; Drug Carriers; Drug Delivery Systems; Epithelial Cells; Excipients; Lactic Acid; Macrophages; Mice; Mucus; Ovalbumin; Polyglutamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Viscosity | 2013 |